NCT00211952View on ClinicalTrials.gov

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

PHASE3SuspendedINTERVENTIONAL

Enrollment

542

Participants

Timeline

Start Date

March 31, 2004

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

celecoxib

Trial Locations (1)

80-211

Medical University of Gdansk, Gdansk

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Central and Eastern European Oncology Group

OTHER

collaborator

Stowarzyszenie Ludzi Wyleczonych z Raka Płuca

UNKNOWN

collaborator

Pharmacia

INDUSTRY

lead

Medical University of Gdansk

OTHER